Your choices regarding cookies on this site

White Paper
The reinsurer found distinct advantages to stacking the datasets, whether interpreted by the Irix Rules Engine or input into Risk Score.
In their study, “What do we gain in underwriting by accessing medical claims data in addition to pharmacy prescriptions?” RGA reports the results of using Irix® Prescription Data and Medical Data, compared to Prescription Data only, in the context of both the Rules Engine and Risk Score. The reinsurer’s findings can help you decide which tool is right for you and what you should do to get the most benefit from your choice.
The authors concluded that:
RGA reports, “The obvious advantage of Irix rules is transparency, and it is helpful in understanding the reasons and sources of the incremental value when Dx is added to Rx data.”
The reinsurer found that adding Medical Data to Risk Score increased the number of applicants eligible for the best class, while it resulted in fewer best-class offers when using the Rules Engine with the original (Prescription Data-only) ruleset.
RGA’s results corroborate our assertion that carriers who adjust guidelines and recalibrate rulesets when adding Medical Data reap its maximum benefit: harnessing new protective value while maintaining issue rates.
Read the white paper
Milliman and our third-party website analytics and performance partners use cookies on our website that may collect and use personal information in order to constantly improve website performance and reliability and to provide accurate and relevant information. By clicking “Accept,” you consent to the placement and use of cookies by Milliman and our third-party partners for these purposes. You can learn more about how this site uses cookies and related technologies by reading our privacy policy